abstract |
The present invention provides a method for diagnosing venous thromboembolism (VTE), comprising: detecting the level of an integrin β1 subunit, an integrin β2 subunit, and/or an integrin β3 subunit in a blood sample. Also provided is a reagent kit for diagnosing the VTE, comprising a substance capable of specifically combining the integrin β1 subunit, the integrin β2 subunit, and/or the integrin β3 subunit. |